2022 WIN Leadership Institute

SITC is excited to announce the 2022 WIN Leadership Institute to be held in-person on Aug. 1-2, 2022 in Seattle, WA. The program, free of charge to accepted applicants, is professional development and a networking event that seek to empower emerging female leaders in the cancer immunotherapy field.

2022 WIN Leadership Institute Organizers

• Lisa H. Butterfield, PhD – University of California, San Francisco
• Olivera J. Finn, PhD – University of Pittsburgh
• Kristen Hege, MD – Bristol Myers Squibb/University of California, San Francisco
  
• Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
• Cornelia L. Trimble, MD – Johns Hopkins University
  

WIn LEadership InsTitute Enduring Materials

Enduring materials will be made available to all program attendees. Attendees should reach out to education@sitcancer.org for access once the program has ended.

The 2022 Women in Cancer Immunotherapy Network (WIN) Leadership Institute is supported*, in part, by grants from: Bristol Myers Squibb, Merck, Incyte, and Wilson Wolf. (As of 07/27/2022)

Travel Award Winners

In an effort to create opportunities that further the mission of SITC and expand the knowledge of and interest in cancer immunotherapy, SITC established the Forward Fund. Since 2014, SITC has awarded more than $5 million in funding to deserving early career scientists.

Made possible through SITC’s Forward Fund, the 2022 Women in Cancer Immunotherapy Network Leadership Institute (WINLI), offered five travel awards to supplement the travel costs for those who applied and were selected to attend this year’s program. Applications were open to all attendees and considered through a variety of factors including a statement of benefit and for those who self-identified as individuals from underrepresented racial and ethnic groups in the biomedical sciences according to the NIH statement*. Two out of the five travel awards were specifically reserved for those from these groups.

*SITC follows the NIH’s Statement on Diversity, as well as their Underrepresented Populations in the U.S Biomedical, Clinical, Behavioral and Social Sciences for the review and selection of SITC’s Women in Cancer Immunotherapy Network Leadership Institute (WIN-LI) Travel Awards. By following the NIH Statement on Diversity, this program aims to enhance diversity by increasing participation of those from underrepresented groups by building, soliciting and including a diverse and inclusive audience.  

Since its inception, SITC has strongly supported the growth and achievement of young investigators in the field of cancer immunotherapy. As the field continues to expand, SITC has realized the even greater importance of fostering the growth and development of the next generation of cancer immunotherapy experts and tumor immunologists by providing them with additional support opportunities.

For more information on the Forward Fund or to contribute, visit
https://www.sitcancer.org/funding/forward-fund/making-a-difference

2022 WIN Leadership Institute Participants

Gitte Holmen Olofsson, PhD

Noa Holtzman, MD

Kazusa Ishii, MD, MPH

Allison Kaeding, MD

Tanya Keenan, MD, MPH

Kelly Kersten, PhD

Emily Keung, MD

Ashley Koegel, MD

Samantha Liang, PhD

Cassandra Lowenstein, MS

Elizabeth, McGehee, MD

Kamaneh Montazeri, MD

Yuki Muroyama, MD, PhD

Elise Nassif, MD

Erin Nevius, PhD

Lily Nti-Kyeremeh

Halley Oyer, PhD

Marisella Panduro, PhD

Nindhana Paranthaman, MD

Soo Park, MD

Elizabeth Pham, PhD

Amanda Przespolewski, DO

Sarwish Rafiq, PhD

Geraldine Raja, PhD

Melissa Reeves, PhD

Dayana Rivadeneira, PhD

Kara Schenk, MD

Morgan Roberts, PhD

Laura Rogers, PhD

Assieh Saadatpour, PhD

Kara Schenk, MD

Fryza Shaikh, MD, PhD

Sophia Shalhout, PhD

Rebecca Shatsky, MD

Kristin Shotts, PhD

Elaine Shum, MD

Sara Smith, PharmD

Shivani Srivastava, PhD

Beatrice Sun, MD

Alankrita Taneja, MD

Diane Tseng, MD, PhD

Babita Verma, PhD

Ruth White, MD, PhD

Mary Young, PhD

Ananya Zutshi, MBA